5-fluorouracil-hyaluronic acid complex - Alchemia

Drug Profile

5-fluorouracil-hyaluronic acid complex - Alchemia

Alternative Names: 5-fluorouracil hyaluronan acid complex; HA-5-fluorouracil; HA-5FU; Hyaluronan acid-5-fluorouracil complex; Hyaluronic acid-5-fluorouracil complex

Latest Information Update: 23 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alchemia
  • Class Antineoplastics; Pyrimidinones; Small molecules
  • Mechanism of Action DNA synthesis inhibitors; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Colorectal cancer

Most Recent Events

  • 23 Jan 2018 No development reported - Phase-I/II for Colorectal cancer (Metastatic disease) in Australia (IV)
  • 01 Dec 2015 Phase-I/II clinical trials in Colorectal cancer in Australia (IV) prior to December 2015
  • 01 Dec 2015 Efficacy and adverse event data from a phase I/II trial released by Alchemia (Alchemia pipeline, December 2015) prior to December 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top